Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Steffan N. Ho"'
Publikováno v:
BioTechniques, Vol 54, Iss 3, Pp 129-133 (2013)
Gene Splicing by Overlap Extension or “gene SOEing” is a PCR-based method of recombining DNA sequences without reliance on restriction sites and of directly generating mutated DNA fragments in vitro. By modifying the sequences incorporated into t
Externí odkaz:
https://doaj.org/article/c2d0755af0f8481f9b83ba1b48b3cfdf
Autor:
Kandasamy Hariharan, Mitchell E. Reff, Steffan N. Ho, Scott M. Glaser, Ingrid Joseph, Keli Perron, Tracey Snipas, Adam Doern, Emma Langley, Susan Tamraz, Arlene Sereno, Stephen J. Demarest, Jianying Dong
The insulin-like growth factor-I receptor (IGF-IR) is a cell surface receptor tyrosine kinase that mediates cell survival signaling and supports tumor progression in multiple tumor types. We identified a spectrum of inhibitory IGF-IR antibodies with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aa0d26ace24705867cece57f7eff17e
https://doi.org/10.1158/1535-7163.c.6531597
https://doi.org/10.1158/1535-7163.c.6531597
Autor:
Kandasamy Hariharan, Mitchell E. Reff, Steffan N. Ho, Scott M. Glaser, Ingrid Joseph, Keli Perron, Tracey Snipas, Adam Doern, Emma Langley, Susan Tamraz, Arlene Sereno, Stephen J. Demarest, Jianying Dong
Related Editorial from Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7051116ff149116d22709be09268ac
https://doi.org/10.1158/1535-7163.22484823
https://doi.org/10.1158/1535-7163.22484823
Autor:
Kandasamy Hariharan, Mitchell E. Reff, Steffan N. Ho, Scott M. Glaser, Ingrid Joseph, Keli Perron, Tracey Snipas, Adam Doern, Emma Langley, Susan Tamraz, Arlene Sereno, Stephen J. Demarest, Jianying Dong
Supplementary Figure 5 from Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca9522aa002bce3471a3f57efb7a9e57
https://doi.org/10.1158/1535-7163.22484808
https://doi.org/10.1158/1535-7163.22484808
Autor:
Kandasamy Hariharan, Mitchell E. Reff, Steffan N. Ho, Scott M. Glaser, Ingrid Joseph, Keli Perron, Tracey Snipas, Adam Doern, Emma Langley, Susan Tamraz, Arlene Sereno, Stephen J. Demarest, Jianying Dong
Supplementary Figure 3 from Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13ea4b28b3e1d7d1d2634449e975efec
https://doi.org/10.1158/1535-7163.22484814
https://doi.org/10.1158/1535-7163.22484814
Autor:
Kandasamy Hariharan, Mitchell E. Reff, Steffan N. Ho, Scott M. Glaser, Ingrid Joseph, Keli Perron, Tracey Snipas, Adam Doern, Emma Langley, Susan Tamraz, Arlene Sereno, Stephen J. Demarest, Jianying Dong
Supplementary Figure 1 from Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a0248d65c2c360db5dfe4bfed496f78
https://doi.org/10.1158/1535-7163.22484820
https://doi.org/10.1158/1535-7163.22484820
Autor:
Kandasamy Hariharan, Mitchell E. Reff, Steffan N. Ho, Scott M. Glaser, Ingrid Joseph, Keli Perron, Tracey Snipas, Adam Doern, Emma Langley, Susan Tamraz, Arlene Sereno, Stephen J. Demarest, Jianying Dong
Supplementary Figure 4 from Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46fc182083fe4cc1edad77c1f280e9ac
https://doi.org/10.1158/1535-7163.22484811.v1
https://doi.org/10.1158/1535-7163.22484811.v1
Autor:
Kandasamy Hariharan, Mitchell E. Reff, Steffan N. Ho, Scott M. Glaser, Ingrid Joseph, Keli Perron, Tracey Snipas, Adam Doern, Emma Langley, Susan Tamraz, Arlene Sereno, Stephen J. Demarest, Jianying Dong
Supplementary Figure 2 from Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::951d3d22282ddb715a7f4719ae897681
https://doi.org/10.1158/1535-7163.22484817
https://doi.org/10.1158/1535-7163.22484817
Autor:
D.R. Camidge, Stephanie Green, Jolanda Paolini, Keith D. Wilner, Marileila Varella-Garcia, Steffan N. Ho, Fiona H Blackhall, Silvana Lanzalone, Yi-Long Wu, K. Pestova, Benjamin Solomon, Alice T. Shaw, Anna Polli, J-C. Soria, Tony Mok, Anthony J. Iafrate
Publikováno v:
Annals of Oncology. 29:1964-1971
Background In clinical trials of patients with anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) treated with crizotinib, evaluation of the relationship between the percentage of ALK-positive cells by fluorescence in situ h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a95578ff2379ab71be2f8aa29d1ba0cc
https://doi.org/10.1093/annonc/mdy242
https://doi.org/10.1093/annonc/mdy242
Autor:
Athanassios Argiris, Steffan N. Ho, Keith D. Eaton, Weiwei Tan, Martin Gutierrez, Francisco Robert, Sai-Hong Ignatius Ou, Ramaswamy Govindan, Gregory A. Otterson, Alain C. Mita, Nicoletta Brega, Tiziana Usari
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol 12, iss 1
J Thorac Oncol
J Thorac Oncol
Introduction This phase I trial was conducted to determine the safety, maximum tolerated dose (MTD)/recommended phase II dose, and efficacy of crizotinib plus erlotinib in patients with advanced NSCLC. Methods Patients with NSCLC and an Eastern Coope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13d637cf76ac24e04c8af4a8991867f
https://doi.org/10.1016/j.jtho.2016.09.131
https://doi.org/10.1016/j.jtho.2016.09.131